Drug-Induced Myoclonus: A Systematic Review
<i>Background and Objectives</i>: Myoclonus is already associated with a wide variety of drugs and systemic conditions. As new components are discovered, more drugs are suspected of causing this disabling abnormal involuntary movement. This systematic review aims to assess the medication...
Saved in:
Main Authors: | Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Nidhi Bhal, Rishikulya Repudi, Lea Zlatin, Ian M. Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/61/1/131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myoclonus
by: R. Rimšienė, et al.
Published: (2020-12-01) -
Paradoxical reactions to midazolam: A case report
by: Shenglin Chi, et al.
Published: (2025-02-01) -
Clinical efficacy of low‐dose Perampanel correlates with neurophysiological changes in familial adult myoclonus epilepsy 2
by: Antonietta Coppola, et al.
Published: (2025-02-01) -
Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis
by: Lu Chen, et al.
Published: (2025-01-01) -
The utilization of the multimodal immunotherapy for the opsoclonus–myoclonus syndrome can reduce relapses and permanent neurological sequelae
by: Fang He, et al.
Published: (2025-02-01)